Diebold Nixdorf, Incorporated ( DBD) - Key Metrics
DBD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $27.06 | $0.45 | -$0.61 | -$0.83 |
| 2026Q1 | $25.41 | $0.14 | $0.90 | $0.74 |
| 2025Q4 | $30.84 | $1.39 | $6.08 | $5.66 |
| 2025Q3 | $25.48 | $1.11 | $1.01 | $0.66 |
| 2025Q2 | $24.60 | $0.33 | $0.81 | $0.34 |
DBD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 47.23 |
| 2026Q1 | 0% | 134.71 |
| 2025Q4 | 0% | 12.21 |
| 2025Q3 | 0% | 12.62 |
| 2025Q2 | 0% | 41.97 |
DBD
Price: $65.04
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.02 USD
P/E Ratio: 21.12
Exchange: NYQ
Sector: Technology
Industry: Software - Application
Volume: 1.9 million
Ebitda: 81.7 millionMarket Capitalization: 2.2 billion